Cargando…
When speed matters: a discussion on the benefits of a grace period in patent law to accelerate pharmaceutical innovation in times of pandemic
The unprecedented coronavirus disease 2019 (COVID-19) pandemic is a solemn reminder of the need to accelerate pharmaceutical innovation. The desire for fast access to vaccines triggered discussion of unrestricted access to research findings with the hope of facilitating the drug discovery process to...
Autores principales: | Ozyhar, Tomasz, Barnabei, Laura, Myrick, Dorkina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882381/ https://www.ncbi.nlm.nih.gov/pubmed/35233290 http://dx.doi.org/10.1093/jlb/lsac004 |
Ejemplares similares
-
Power Law Distributions of Patents as Indicators of Innovation
por: O’Neale, Dion R. J., et al.
Publicado: (2012) -
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
por: Gurgula, Olga
Publicado: (2020) -
Benefit Design Innovations to Manage Specialty Pharmaceuticals
por: Stern, Debbie
Publicado: (2008) -
Patently Innovative
por: Bouchard, R
Publicado: (2012) -
Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents
por: Jiang, Qiaolei, et al.
Publicado: (2018)